Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation
Sponsor: Fundació Sant Joan de Déu
Summary
This double-blind, randomized, placebo-controlled parallel trial evaluates the effects of maternal 5-methyltetrahydrofolate (5-MTHF) supplementation during breastfeeding. Thirty-six lactating mother-infant dyads will be randomized (1:1) to receive 5-MTHF or placebo for 6 weeks, stratified by infant sex and mode of delivery. Tolerability and adverse events will be monitored. Pre- and post-intervention assessments include breast milk one-carbon metabolites and oligosaccharides; maternal plasma one-carbon metabolites and metabolic health markers. Maternal mental health will be evaluated using the SCL-90-R questionnaire. A follow-up visit at 4 months will reassess infant anthropometry and microbiome outcomes.
Key Details
Gender
FEMALE
Age Range
18 Years - 42 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2026-04-15
Completion Date
2027-02-28
Last Updated
2026-04-02
Healthy Volunteers
No
Conditions
Interventions
5-MTHF Supplementation
Oral supplementation with 5-MTHF (800 µg) administered daily for 6 weeks during lactation.
Placebo
Matching placebo administered daily for 6 weeks during lactation.
Locations (2)
Hospital Sant Joan de Deu
Barcelona, Barcelona, Spain
Hospital Sant Joan de Déu
Barcelona, Barcelona, Spain